Charles M. Roth

Our research involves the application of molecular and nanobioengineering approaches to cancer, infection, and other biomedical problems. Much of our work centers on the development of technology for efficient delivery of oligonucleotides (antisense or short interfering RNA) for gene silencing and antimicrobial drugs for infection control. Current projects include: (1) aerosolized nanomedicine for lung infections; (2) nanomaterials for antimicrobial drug delivery to wounds; (3) physiologically based pharmacokinetic modeling of nanomedicines.

•    2015 Outstanding Engineering Faculty Award, Rutgers University
•    2013 Fellow, American Institute of Medical and Biological Engineering
•    2011-2017 Member, NIH Gene and Drug Delivery Study Section
•    2008 Warren I. Susman Award for Excellence in Teaching
•    2005 Rutgers, FASIP Award for Teaching, Research and Service (ranked first in Department)
•    2003 NSF Faculty CAREER Award
•    2002, 2006 Charles & Johanna Busch Biomedical Research Award
•    2002 Whitaker Foundation Transitional Career Award
•    2000 Whitaker Foundation Travel Award
•    1998-99 Harvard Council on Biomedical Engineering Faculty Excellence Fellow
•    1995-97 NIH Postdoctoral Fellowship
 

•    Department of Chemical and Biochemical Engineering
•    Graduate Program in Biochemistry
•    Graduate Program in Cell and Developmental Biology
•    New Jersey Center for Biomaterials
•    Cancer Institute of New Jersey
 

•    Postdoctoral, Bioengineering, Harvard Medical School, 1995-97
•    Ph.D., Chemical Engineering, University of Delaware, 1994
•    B.S.E., Chemical Engineering, University of Pennsylvania, 1989